ARTICLE | Clinical News
Vaxem-Hib regulatory update
October 7, 2013 7:00 AM UTC
Takeda submitted an NDA to Japan's Ministry of Health, Labor and Welfare for TAK-816 to prevent Haemophilus influenzae type B (Hib) infection in children. The product is a vaccine containing polyribos...